bioRxivPharmacology & ToxicologyPreprint
Evaluation of resistant starch from teff (Eragrostis tef) grain as a film coating material for colon-targeted drug delivery
Abstract
Teff (Eragrostis tef, family Poaceae) is a native cereal crop widely grown in Ethiopia, containing approximately 73% carbohydrates, of which about 30% is resistant starch. This study evaluates resistant starch extracted from teff grain as a film coating material for colon-targeted delivery of metronidazole, used as a model drug. Starch was extracted from teff and resistant starch was isolated from the total starch. Metronidazole core tablets were prepared by wet granulation, compressed, and coated with a resistant starch-based film. The physicochemical properties of the tablets were evaluated in vitro. To prevent premature film disruption caused by the swelling of amylose, a dominant component of resistant starch, a water-insoluble polymer, ethylcellulose, was added. Various proportions of amylose and ethylcellulose were used as film coating materials and evaluated in simulated conditions to determine the optimal combination for drug release in the colon, but not in the upper gastrointestinal tract. The results of the dissolution and fermentation studies indicated the best film coating proportions of amylose to ethylcellulose and the corresponding thicknesses in percentage of total weight gain were: 1:1 ratio at 6% thickness, 1:2 ratio at 4% and 6% thickness, and 1:3 ratio at 2% and 4% thickness. The targeted drug release of the film material is attributed to bacterial enzyme digestion of the resistant starch component in the colon. The digestion of resistant starch creates pores in the ethylcellulose film scaffold, leading to the disruption of the film and release of the drug exclusively in the colon, where the bacterial microflora reside. Based on these results, resistant starch from teff grain shows potential as a colon-targeting excipient.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DEVELOPMENT AND CHARACTERIZATION OF A NEW ENDOSCOPIC DRUG ELUTING PLATFORM WITH PROVEN EFFICACY IN ACUTE AND CHRONIC EXPERIMENTAL COLITIS
I. Bon, M. Cano-Sarabia, … V. Lorenzo-Zuniga·bioRxiv·Jul 23, 2019
- Design And Optimization Studies Of Tablet In Tablet Formulation Of Diclofenac And Misoprostol: Application Of Response Surface Methodolgy And Compressional Behaviour Strategy
S. N. Shah, H. Ali, … N. Aslam·bioRxiv·Nov 4, 2022
- Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitis
M. Carone, M. R. Spalinger, … S. Aleandri·bioRxiv·Sep 28, 2022
- Shifting Perspectives on Biotherapeutic Treatment in Ulcerative Colitis using Lipid Mesophases: Formulation Design and Preclinical Validation
Rafaela Pletsch Gazzi, Cremona Tiziana, … Simone Aleandri·bioRxiv·Feb 10, 2026
- Chitosan-olive oil microparticles for phenylethyl isothiocyanate delivery: optimal formulation
E. R. Coscueta, A. S. Sousa, … M. M. Pintado·bioRxiv·Feb 24, 2021
- Aceclofenac Fast Dispersible Tablet Formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics
M. H. Shoaib, R. Yasmin, … F. Zafar·bioRxiv·Sep 20, 2019